Oncopeptides will host a webcaston Monday, January 27th 2020 were CEO Jakob Lindberg will present and explain melflufen’s mechanism of action. The presentation will be available below just before the start of the webcast.
Conference call for investors, analysts and the media, Monday, January 27th 2020, at 11 (CET)
Phone numbers for participants from:
Sweden: +46 8 56642651
Europe: +44 6319131422
USA: +1 3333000804
Participant Pin code:
The conference call will also be streamed via the link below: